Compare · BLCO vs LUCY
BLCO vs LUCY
Side-by-side comparison of Bausch + Lomb Corporation (BLCO) and Innovative Eyewear Inc. (LUCY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLCO and LUCY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- BLCO is the larger of the two at $5.80B, about 1038.7x LUCY ($5.6M).
- Over the past year, BLCO is up 18.7% and LUCY is down 60.8% - BLCO leads by 79.5 points.
- LUCY has been more active in the news (6 items in the past 4 weeks vs 3 for BLCO).
- BLCO has more recent analyst coverage (18 ratings vs 0 for LUCY).
- Company
- Bausch + Lomb Corporation
- Innovative Eyewear Inc.
- Price
- $16.29+1.94%
- $0.85-10.58%
- Market cap
- $5.80B
- $5.6M
- 1M return
- +7.88%
- -2.68%
- 1Y return
- +18.73%
- -60.78%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- 2022
- News (4w)
- 3
- 6
- Recent ratings
- 18
- 0
Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions. It offers intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Latest BLCO
- Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
- Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
- Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
- President, Surgical Bonnefoy Luc covered exercise/tax liability with 1,008 shares, decreasing direct ownership by 1% to 87,023 units (SEC Form 4) to satisfy tax liability
- SEC Form SD filed by Bausch + Lomb Corporation
- Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
- Director Von Eschenbach Andrew C. was granted 15,842 shares, increasing direct ownership by 22% to 86,656 units (SEC Form 4)
- Director Ross Thomas W. Sr. was granted 15,842 shares, increasing direct ownership by 23% to 85,233 units (SEC Form 4)
- Director Robertson Russel C was granted 15,842 shares, increasing direct ownership by 20% to 94,260 units (SEC Form 4)
- Director Paulson John was granted 15,842 shares, increasing direct ownership by 21% to 89,823 units (SEC Form 4)
Latest LUCY
- Innovative Eyewear, Inc. Announces New Claude AI Integration for All Lucyd Smart Eyewear
- Innovative Eyewear Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds
- Innovative Eyewear, Inc. Announces 345-Store Rollout with FYihealth Group
- Innovative Eyewear Q2 2026 Net Sales Up 71% Year-Over-Year in Twelfth Consecutive Quarter of Growth
- Innovative Eyewear, Inc. Partners with Encore Optical Laboratory to Provide New Lens Technologies for Smart Eyewear
- Innovative Eyewear Inc. Reports Q1 2026 Unaudited Financial Results
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Real-Time AI Translated Calls for the Lucyd App
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.